Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial - Wikidata - awgldk - TriplyDB

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial

http://www.wikidata.org/entity/Q33733790

about

Forty years of landmark trials undertaken by the Danish Breast Cancer Cooperative Group (DBCG) nationwide or in international collaboration.Axillary lymph node dissection in breast cancer patients after sentinel node biopsy.

P2860

Q47368780-4019EA14-B4FF-45A8-86D4-FA248A7850F5 Q48247748-0BB9B614-010F-40AD-9765-83B4D2BF7E7D

P2860

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial

http://www.wikidata.org/entity/Q33733790

description

2017 nî lūn-bûn

@nan

2017 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2017 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

name

Survival and axillary recurren ...... mized controlled SENOMAC trial

@ast

Survival and axillary recurren ...... mized controlled SENOMAC trial

@en

type

label

Survival and axillary recurren ...... mized controlled SENOMAC trial

@ast

Survival and axillary recurren ...... mized controlled SENOMAC trial

@en

prefLabel

Survival and axillary recurren ...... mized controlled SENOMAC trial

@ast

Survival and axillary recurren ...... mized controlled SENOMAC trial

@en

P1433

Q33733790-461BFC3E-0CF8-4DAE-8976-65CD43C12029

P1476

Q33733790-36C40939-AC1D-4CB6-BFEA-235966A0439D

P2093

Q33733790-0BF74723-93BA-497B-84A1-59B86CEC05C9

Q33733790-30946843-1906-426B-8C7B-A712E0C014F8

Q33733790-54EBF583-304A-4B44-880B-78EF0F06F044

Q33733790-5AD0D3D8-2708-4785-87AB-7CC0972DC4B1

Q33733790-6963CEE2-80B2-4641-8C17-8D13AC2F2324

Q33733790-7806BAA2-E9BC-487C-AF53-256CA604DA49

Q33733790-81B51598-FE26-4B4A-BE5E-17697B56B417

Q33733790-BBA89D1D-BB29-425F-A821-774E1A91FD71

Q33733790-C76A7EAC-AAAB-434E-BCCC-6F7B13940B74

P2860

Q33733790-07F84DA1-847C-4DA2-977E-97C5FBDB4E2B

Q33733790-0A4997BB-88CF-44A0-AE31-AAF2CBAA836B

Q33733790-12DB0D56-E06F-45E5-82E6-95C763D88DB4

Q33733790-19E5B411-35AD-4D15-84E9-9CBCD044A0B1

Q33733790-22A72C66-315E-47F5-B0AC-48881E8FBEC3

Q33733790-2574F12D-B742-4901-AFF8-4770C26EA4D6

Q33733790-2FFA9547-07C9-4342-A4DC-D8B231B89AA8

Q33733790-356FDC6C-23EF-474C-A180-A87949D279C4

Q33733790-38AD9782-9281-4FF6-984A-24A0C9DE7C0B

Q33733790-3D3313EA-4C49-424A-954F-BDD778B9C4FE

P2888

Q33733790-37269805-A37E-4F78-B14E-044619D25238

P304

Q33733790-64D76198-5A67-4894-95A0-8D06CC95A42B

P31

Q33733790-47A9F7E7-FABE-4148-9065-698CCF4EA9A0

P356

Q33733790-2789FAB7-6678-453D-BDE7-B5F08F45B056

P407

Q33733790-792DE44C-21DE-4DA1-9500-8D8589478569

P433

Q33733790-19B28D99-C4F5-4136-BD28-B89DE8CD1105

P478

Q33733790-00672F92-B8D7-4E75-A92C-34EBFA9EBA11

P50

Q33733790-9FC62FFF-AB62-460C-BD28-1521146D8B59

Q33733790-FCC54D1E-FF40-4D7A-8907-C7BEFBEC2A91

P577

Q33733790-9AE3B7CD-4864-447A-A572-6527BF5D4188

P6179

Q33733790-1710778E-58BA-4C65-8AA3-9355650AB798

P698

Q33733790-8D608510-08F1-4D77-912F-6ED57BF86FD2

P932

Q33733790-B978EE74-28B0-475F-9777-C296DD3257B3

P356

S12885-017-3361-Y

P1433

P1476

Survival and axillary recurren ...... mized controlled SENOMAC trial

@en

P2093

Dan Lundstedt

http://www.w3.org/2001/XMLSchema#string

Hemming Johansson

http://www.w3.org/2001/XMLSchema#string

Jan Frisell

http://www.w3.org/2001/XMLSchema#string

Johan Ahlgren

http://www.w3.org/2001/XMLSchema#string

Leif Bergkvist

http://www.w3.org/2001/XMLSchema#string

Lisa Rydén

http://www.w3.org/2001/XMLSchema#string

Malin Sund

http://www.w3.org/2001/XMLSchema#string

SENOMAC Trialists’ Group

http://www.w3.org/2001/XMLSchema#string

Yvette Andersson

http://www.w3.org/2001/XMLSchema#string

P2860

Axillary surgery in women with sentinel node-positive operable breast cancer: a systematic review with meta-analyses

Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial

The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology

Lymphatic mapping and sentinel lymph node biopsy in breast cancer.

Safety of avoiding routine use of axillary dissection in early stage breast cancer: a systematic review.

Patient-reported outcomes in sentinel node-negative adjuvant breast cancer patients receiving sentinel-node biopsy or axillary dissection: National Surgical Adjuvant Breast and Bowel Project phase III protocol B-32.

Sentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial

Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L).

Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial

American College of Surgeons Oncology Group (ACOSOG) Z0011: impact on surgeon practice patterns.

P2888

s12885-017-3361-y

P304

379

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-017-3361-Y

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

17

http://www.w3.org/2001/XMLSchema#string

P50

Roger Olofsson Bagge

Jana de Boniface

P577

2017-05-26T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1085601546

http://www.w3.org/2001/XMLSchema#string

P698

28549453

http://www.w3.org/2001/XMLSchema#string

P932

5446737

http://www.w3.org/2001/XMLSchema#string